Under-eye Botox—often called jelly roll Botox—is a small-dose neuromodulator treatment used to soften a muscle bulge or dynamic lines that appear directly beneath the lower eyelid when a person smiles or squints.
The most important question is not simply “Can Botox go under the eyes?” It is “What is actually causing the concern, and is relaxing the lower-eyelid muscle likely to help without weakening eyelid function?”
BOTOX Cosmetic is FDA-approved for several aesthetic areas, including lateral canthal lines—commonly called crow’s feet—beside the eyes. The current U.S. label does not list direct lower-eyelid or under-eye treatment as an approved cosmetic indication. Off-label prescribing is legally permitted for licensed clinicians, but the evidence base and standardized labeling are more limited for this specific location.
Not Sure What Is Causing Your Under-Eye Concern?
A consultation can distinguish muscle-related jelly rolls from hollowness, pigmentation, fluid retention, skin laxity, or true lower-eyelid bags before a treatment is selected.
Book a Consultation Treatment suitability and results vary by anatomy and medical historyWhat Is Under-Eye Botox?
Under-eye Botox is a patient-facing term for the use of onabotulinumtoxinA or another botulinum toxin product in the lower-eyelid region. The target is usually a visible roll or crease created when the pretarsal portion of the orbicularis oculi muscle contracts during smiling or squinting.
The orbicularis oculi is a circular muscle involved in eyelid closure and blinking. Carefully reducing activity in a selected portion may soften a dynamic bulge or fine movement-related lines. Because this muscle also supports normal eyelid function and tear distribution, the goal is a subtle change—not complete paralysis.
Is Under-Eye Botox FDA-Approved?
Direct lower-eyelid cosmetic treatment is not listed among the current FDA-approved BOTOX Cosmetic aesthetic indications. The FDA label includes moderate-to-severe glabellar lines, lateral canthal lines, forehead lines, and platysma bands in adults.
Crow’s-feet treatment is performed in the lateral orbicularis oculi beside the eye. Jelly roll treatment is closer to the lower eyelid. These are not the same treatment area, even though both involve portions of the orbicularis oculi muscle.
What Under-Eye Botox May—and May Not—Treat
Jelly Roll During Smiling
A small bulge immediately beneath the lower lash line that appears mainly with smiling or squinting and decreases at rest.
Fine Dynamic Creasing
Selected movement-related lines caused primarily by lower-eyelid muscle contraction in a person with adequate eyelid tone.
Tear-Trough Hollows
Shadowing from volume loss or facial anatomy is not corrected by relaxing a muscle and may require a different approach.
Dark-Circle Pigmentation
Brown or blue discoloration from pigment, visible vessels, allergy, or thin skin generally needs diagnosis-specific treatment.
True Eye Bags or Chronic Puffiness
Fat herniation, edema, malar bags, or impaired lymphatic drainage may remain unchanged or look more prominent if muscle support is reduced.
Loose or Weak Lower Eyelids
Pre-existing laxity, incomplete closure, dry eye, or poor eyelid support may increase the risk of irritation, lid malposition, or exposure symptoms.
A correct diagnosis of the under-eye concern matters more than the popularity of a particular injectable.
How Botulinum Toxin Works
OnabotulinumtoxinA blocks acetylcholine release at the neuromuscular junction, temporarily reducing contraction in the injected muscle. The chemical-denervation effect may begin within one to two days and increases during the first week for labeled cosmetic treatment areas.
Nerve signaling gradually recovers, so the effect is temporary. The FDA label describes an approximate three-to-four-month duration for glabellar treatment; under-eye duration is less standardized because the use is off-label and typically involves a more conservative approach.
Who May Be a Candidate?
Features That May Support Treatment
- A visible jelly roll mainly during smiling or squinting
- Good lower-eyelid tone and support
- No significant dry-eye or exposure symptoms
- No prominent fat-pad bag, edema, or severe laxity
- Realistic expectations for a subtle, temporary change
- Willingness to accept off-label treatment after informed consent
Questions a Clinician May Ask
- Does the bulge exist at rest or only with expression?
- Do your eyes feel dry, gritty, painful, or light-sensitive?
- Can you fully close both eyes?
- Have you had eyelid surgery, filler, laser, or prior toxin?
- Do you have facial weakness or a neuromuscular condition?
- Are you taking medicines that affect neuromuscular transmission?
Who May Need Another Option or Additional Evaluation?
Treatment may be inappropriate, delayed, or modified when the risk of functional change outweighs the likely cosmetic benefit.
- Active infection, rash, or inflammation at the proposed injection site
- Known serious hypersensitivity to a botulinum toxin product or an ingredient
- Pre-existing lower-lid laxity, ectropion, lagophthalmos, or difficulty closing the eye
- Moderate-to-severe dry eye, corneal disease, or persistent eye irritation
- Prior lower-eyelid surgery with altered support or sensation
- Prominent eye bags, festoons, malar edema, or chronic fluid retention
- Neuromuscular disorders such as myasthenia gravis or Lambert-Eaton syndrome
- Pregnancy, planned pregnancy, or breastfeeding questions that require clinician discussion
- Use of aminoglycoside antibiotics, muscle relaxants, another botulinum toxin, or medicines that may increase weakness
- Expectations that Botox will remove pigmentation, restore volume, or permanently tighten loose skin
What a Good Under-Eye Consultation Should Check
A high-quality assessment is dynamic. The clinician should examine the lower eyelids at rest, while smiling, while squinting, and during blinking—not only in a still photograph.
1. Identify the Cause
Muscle contraction, volume loss, pigment, vascular show, skin laxity, fat herniation, edema, allergy, or a combination.
2. Check Eyelid Function
Lower-lid tone, blink completeness, closure, tear symptoms, asymmetry, prior surgery, and eye-surface health.
3. Review Medical History
Allergies, neuromuscular conditions, eye disease, prior injectables, medicines, pregnancy status, and recent procedures.
4. Discuss Alternatives
Skincare, pigment treatment, resurfacing, PRF/PRP, filler, or oculoplastic surgery may fit another diagnosis better.
5. Set a Conservative Goal
Reduce a specific dynamic roll while preserving blink, eyelid position, eye comfort, and natural smiling.
6. Explain Follow-Up
How to contact the clinic, when results will be reviewed, and what symptoms require urgent evaluation.
What to Expect During Treatment
The appointment generally includes photographs, facial-expression assessment, cleansing of the treatment area, informed consent, and a small number of carefully selected injections. The exact product, dose, dilution, and placement are clinical decisions based on anatomy and should not be copied from an online diagram.
People often describe a brief pinching sensation. Small injection-site bumps, redness, or tenderness can appear temporarily. Cosmetic injections are usually performed in an outpatient medical setting, and most people return to ordinary non-strenuous activities the same day.
Results Timeline and Duration
Small bumps, pinpoint redness, tenderness, or mild swelling may occur. The wrinkle or jelly roll usually looks unchanged at first.
General BOTOX Cosmetic muscle effects may begin within one to two days, but timing varies and a lower-eyelid result may remain subtle.
The effect commonly becomes easier to judge during the first two weeks. Avoid requesting an early touch-up before the clinician’s planned reassessment.
A follow-up can assess symmetry, blink, eyelid position, dry-eye symptoms, smile movement, and whether the conservative goal was achieved.
Muscle activity gradually returns. General cosmetic effects often last about three to four months, but under-eye duration can be shorter or longer.
Risks, Side Effects, and Complications
Common Short-Term Reactions
- Temporary redness, swelling, tenderness, or small bumps
- Bruising at an injection site
- Headache or a temporary heavy sensation
- Temporary asymmetry while the effect develops
Location-Specific Risks
- Dry, gritty, irritated, watery, or light-sensitive eyes
- Reduced blink strength or incomplete eyelid closure
- Lower-lid drooping or outward turning (ectropion)
- Increased under-eye puffiness or altered lymphatic drainage
- Changes in smile animation or lower-face asymmetry
- Upper-eyelid or brow drooping from unintended spread
- Blurred vision or double vision
The FDA label specifically notes reports of dry eye after BOTOX Cosmetic injection in or near the orbicularis oculi muscle and advises ophthalmology referral when irritation, light sensitivity, or visual changes persist.
Preparation and Aftercare
Before the Appointment
- Give the clinician a complete list of prescription medicines, over-the-counter medicines, vitamins, and supplements.
- Report all previous botulinum toxin products and when they were administered.
- Tell the clinician about dry eye, vision changes, eyelid surgery, facial weakness, swallowing problems, and neuromuscular disease.
- Avoid scheduling treatment when an infection, rash, or significant eye irritation is present.
- Arrive with a clean face when instructed by the clinic.
After the Appointment
- Follow the treating clinician’s written instructions.
- Do not rub or massage the treated area unless specifically instructed.
- Use clean hands and gentle skincare around injection sites.
- Ask the clinic when to resume strenuous exercise, heat exposure, makeup, facial treatments, or massage.
- Contact the clinic rather than attempting to correct asymmetry or weakness yourself.
- Allow the planned review period before judging the final result.
Alternatives Based on the Cause of the Under-Eye Concern
| Main Concern | Potential Options to Discuss | Important Limitation or Risk |
|---|---|---|
| Jelly roll visible with smiling | Conservative lower-eyelid neuromodulator in a carefully selected patient | Off-label; may affect blink, lid support, puffiness, or smile movement |
| Crow’s feet beside the eyes | FDA-labeled lateral canthal treatment with BOTOX Cosmetic or another appropriate neuromodulator | Does not directly replace lost volume or remove pigment |
| Tear-trough hollow or shadow | Observation, makeup, selected filler, fat transfer, or surgical assessment | Under-eye filler can cause edema, lumps, discoloration, vascular occlusion, and rare visual complications |
| Brown pigmentation | Sun protection, topical therapy, chemical peel, or selected laser treatment | Requires pigment diagnosis and skin-type-appropriate treatment |
| Thin, crepey skin and fine static lines | Skincare, resurfacing laser, microneedling, radiofrequency, or PRF/PRP | Results, downtime, and risks vary by device and skin type |
| True fat-pad bags or excess skin | Oculoplastic or facial plastic surgery consultation for lower blepharoplasty | Surgery has anesthesia, healing, scarring, dryness, lid-position, and revision risks |
| Allergy-related swelling or chronic edema | Medical evaluation and treatment of the underlying cause | Cosmetic injections may not address the cause and can complicate swelling |
Combination treatment may be appropriate, but “more procedures” is not automatically better. A staged plan can reduce the risk of overcorrection and make it easier to identify which treatment created a benefit or complication.
Cost and Product Considerations
Under-eye neuromodulator pricing varies by product, clinician expertise, location, consultation structure, and whether other areas are treated during the same visit. Because the lower eyelid generally requires conservative planning, the total price may be based on an area fee rather than simply multiplying a published price per unit.
- Cosmetic treatment is generally not covered by health insurance.
- Ask whether consultation, follow-up, and medically appropriate reassessment are included.
- Confirm the exact product name and that it is FDA-approved and obtained through legitimate medical channels.
- Do not select an injector only by the cheapest advertised unit price.
- Do not compare the number of units across different toxin brands as though they are equivalent.
How to Choose a Qualified Provider
Because lower-eyelid treatment is technically demanding and off-label, choose a licensed medical clinician with substantial experience in facial anatomy, neuromodulators, and periocular assessment.
Questions to Ask
- Is this treatment off-label, and why do you recommend it for my specific concern?
- How do you assess lower-eyelid laxity, blink, and dry-eye risk?
- What alternatives could address my concern more directly?
- Which product will be used, and where was it obtained?
- What result is realistic, and what will not change?
- What symptoms require an urgent call or eye examination?
- Who will evaluate me if I develop weakness, visual symptoms, or asymmetry?
- When is the planned follow-up?
Red Flags
- No medical history or eye-symptom review
- No explanation that direct under-eye treatment is off-label
- Guaranteed removal of bags, dark circles, or hollows
- Pressure to treat immediately without discussing alternatives
- Injections in a home, hotel room, party, or other non-medical environment
- Unlabeled, prefilled, counterfeit, imported, or online-purchased product
- No contact pathway for complications
Get an Anatomy-Based Under-Eye Assessment
The right plan starts by identifying whether the concern comes from muscle movement, skin, pigment, volume, fat pads, fluid, or eyelid support.
Schedule an Evaluation Green Relief Health · (410) 368-0420Frequently Asked Questions
No. Crow’s-feet treatment targets lateral canthal lines beside the eyes and is an FDA-approved BOTOX Cosmetic indication. Direct treatment beneath the lower eyelid is a different, off-label application.
It may soften a muscle-related jelly roll that appears during smiling. It does not remove herniated fat, excess skin, malar bags, or chronic edema and can sometimes make puffiness more noticeable.
Not reliably. Dark circles may result from pigment, visible blood vessels, hollowness, shadow, allergy, or thin skin. Botulinum toxin does not directly correct those causes.
General cosmetic BOTOX effects often last approximately three to four months. Direct lower-eyelid use is off-label, and the duration may differ depending on product, dose, anatomy, metabolism, and treatment plan.
Initial effects may begin within a few days, with a more complete assessment commonly performed around two weeks. Follow the review schedule set by the treating clinician.
Yes. The FDA label reports dry eye after BOTOX Cosmetic injections in or near the orbicularis oculi. Persistent irritation, light sensitivity, pain, or visual changes should be evaluated promptly, sometimes by an ophthalmologist.
It can. Product spread or changes in the balance of periocular and upper-cheek muscles may alter smile animation or create asymmetry. This is one reason conservative, anatomy-based treatment is important.
Do not stop a prescribed medicine on your own. Tell the injector what you take and ask the prescribing clinician whether any change is medically appropriate. Preventing a clot, stroke, or heart event is more important than reducing cosmetic bruising.
They address different problems. Botox reduces selected muscle activity; filler adds volume. Filler may suit some hollows but has important risks, including swelling, lumps, vascular occlusion, and rare vision-threatening complications. Neither is automatically the correct choice.
Pre-existing dry eye may increase concern because orbicularis oculi function helps blinking and tear distribution. A clinician should assess severity, eyelid closure, current eye treatment, and whether ophthalmology input is needed.
No. Botulinum toxin effects gradually wear off as neuromuscular signaling recovers. Repeated treatment is required to maintain an effect, provided continued treatment remains appropriate.
Emergency symptoms include trouble breathing, swallowing, or speaking; generalized weakness; or a serious allergic reaction. Urgent eye assessment is appropriate for inability to close the eye, severe eye pain, marked redness or light sensitivity, or new persistent visual disturbance.
Related Green Relief Health Guides
Medical References
- U.S. Food and Drug Administration. BOTOX Cosmetic (onabotulinumtoxinA) Prescribing Information. Revised October 2024.
- Flynn TC, Carruthers A, Carruthers J. Botulinum A toxin in the lower eyelid: dose-finding study. Dermatologic Surgery. 2003.
- Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatologic Surgery. 2001.
- Ozgur O, Murariu D, Parsa AA, Parsa FD. Dry eye syndrome due to botulinum toxin type-A injection. Hawaii Journal of Medicine & Public Health. 2012.
- American Society of Plastic Surgeons. Botulinum Toxin Risks and Safety.
- American Academy of Ophthalmology. Botox for Eye Conditions.
Discuss the Safest Option for Your Under-Eye Anatomy
An in-person assessment can determine whether the concern is muscle-related or would be better addressed with another medical or aesthetic approach.
Book Your Appointment Green Relief Health · Call (410) 368-0420
